0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Canine Vaccine Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-39F18506
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Canine Vaccine Market Research Report 2024
BUY CHAPTERS

Global Canine Vaccine Market Research Report 2024

Code: QYRE-Auto-39F18506
Report
November 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Canine Vaccine Market Size

The global Canine Vaccine market was valued at US$ 1645 million in 2023 and is anticipated to reach US$ 2457 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.

Canine Vaccine Market

Canine Vaccine Market

Canine vaccines can be divided into two categories: core vaccines and non-core vaccines. The so-called core vaccines are vaccines that are necessary for serious diseases with high infectiousness and high mortality rates, including rabies virus, distemper virus, canine adenovirus and canine parvovirus. Non-core vaccines can be evaluated based on the dog's living environment and physical condition to determine whether to vaccinate, including canine parainfluenza virus, leptospirosis, etc.
North American market for Canine Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Canine Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Canine Vaccine include Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, Durvet, Elanco, RuiPu Bio-Technology, CAHIC, Wuhan Keqian Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Canine Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Vaccine.
The Canine Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Canine Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Canine Vaccine Market Report

Report Metric Details
Report Name Canine Vaccine Market
Accounted market size in 2023 US$ 1645 million
Forecasted market size in 2030 US$ 2457 million
CAGR 5.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Core Vaccines
  • Non-Core Vaccines
Segment by Application
  • Puppies
  • Adult Dogs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, Durvet, Elanco, RuiPu Bio-Technology, CAHIC, Wuhan Keqian Biology, Jilin Five-Star Animal Health, NeoTech, JINHE, SINOVAC, Biogenesis Bago
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Canine Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Canine Vaccine Market growing?

Ans: The Canine Vaccine Market witnessing a CAGR of 5.9% during the forecast period 2024-2030.

What is the Canine Vaccine Market size in 2030?

Ans: The Canine Vaccine Market size in 2030 will be US$ 2457 million.

Who are the main players in the Canine Vaccine Market report?

Ans: The main players in the Canine Vaccine Market are Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, Durvet, Elanco, RuiPu Bio-Technology, CAHIC, Wuhan Keqian Biology, Jilin Five-Star Animal Health, NeoTech, JINHE, SINOVAC, Biogenesis Bago

What are the Application segmentation covered in the Canine Vaccine Market report?

Ans: The Applications covered in the Canine Vaccine Market report are Puppies, Adult Dogs

What are the Type segmentation covered in the Canine Vaccine Market report?

Ans: The Types covered in the Canine Vaccine Market report are Core Vaccines, Non-Core Vaccines

Recommended Reports

Animal Vaccines

Dog Healthcare

Dog Food & Supplements

1 Canine Vaccine Market Overview
1.1 Product Definition
1.2 Canine Vaccine by Type
1.2.1 Global Canine Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Core Vaccines
1.2.3 Non-Core Vaccines
1.3 Canine Vaccine by Application
1.3.1 Global Canine Vaccine Market Value by Application (2024-2030)
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Global Canine Vaccine Market Size Estimates and Forecasts
1.4.1 Global Canine Vaccine Revenue 2019-2030
1.4.2 Global Canine Vaccine Sales 2019-2030
1.4.3 Global Canine Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Canine Vaccine Market Competition by Manufacturers
2.1 Global Canine Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Canine Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Canine Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Canine Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Canine Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Canine Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Canine Vaccine, Date of Enter into This Industry
2.8 Global Canine Vaccine Market Competitive Situation and Trends
2.8.1 Global Canine Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Canine Vaccine Players Market Share by Revenue
2.8.3 Global Canine Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Canine Vaccine Market Scenario by Region
3.1 Global Canine Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Canine Vaccine Sales by Region: 2019-2030
3.2.1 Global Canine Vaccine Sales by Region: 2019-2024
3.2.2 Global Canine Vaccine Sales by Region: 2025-2030
3.3 Global Canine Vaccine Revenue by Region: 2019-2030
3.3.1 Global Canine Vaccine Revenue by Region: 2019-2024
3.3.2 Global Canine Vaccine Revenue by Region: 2025-2030
3.4 North America Canine Vaccine Market Facts & Figures by Country
3.4.1 North America Canine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Canine Vaccine Sales by Country (2019-2030)
3.4.3 North America Canine Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Canine Vaccine Market Facts & Figures by Country
3.5.1 Europe Canine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Canine Vaccine Sales by Country (2019-2030)
3.5.3 Europe Canine Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Canine Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Canine Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Canine Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Canine Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Canine Vaccine Market Facts & Figures by Country
3.7.1 Latin America Canine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Canine Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Canine Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Canine Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Canine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Canine Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Canine Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Canine Vaccine Sales by Type (2019-2030)
4.1.1 Global Canine Vaccine Sales by Type (2019-2024)
4.1.2 Global Canine Vaccine Sales by Type (2025-2030)
4.1.3 Global Canine Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Canine Vaccine Revenue by Type (2019-2030)
4.2.1 Global Canine Vaccine Revenue by Type (2019-2024)
4.2.2 Global Canine Vaccine Revenue by Type (2025-2030)
4.2.3 Global Canine Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Canine Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Canine Vaccine Sales by Application (2019-2030)
5.1.1 Global Canine Vaccine Sales by Application (2019-2024)
5.1.2 Global Canine Vaccine Sales by Application (2025-2030)
5.1.3 Global Canine Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Canine Vaccine Revenue by Application (2019-2030)
5.2.1 Global Canine Vaccine Revenue by Application (2019-2024)
5.2.2 Global Canine Vaccine Revenue by Application (2025-2030)
5.2.3 Global Canine Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Canine Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Canine Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Animal Health Canine Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Canine Vaccine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Canine Vaccine Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Durvet
6.6.1 Durvet Company Information
6.6.2 Durvet Description and Business Overview
6.6.3 Durvet Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Durvet Canine Vaccine Product Portfolio
6.6.5 Durvet Recent Developments/Updates
6.7 Elanco
6.7.1 Elanco Company Information
6.7.2 Elanco Description and Business Overview
6.7.3 Elanco Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Elanco Canine Vaccine Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 RuiPu Bio-Technology
6.8.1 RuiPu Bio-Technology Company Information
6.8.2 RuiPu Bio-Technology Description and Business Overview
6.8.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
6.8.5 RuiPu Bio-Technology Recent Developments/Updates
6.9 CAHIC
6.9.1 CAHIC Company Information
6.9.2 CAHIC Description and Business Overview
6.9.3 CAHIC Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CAHIC Canine Vaccine Product Portfolio
6.9.5 CAHIC Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Company Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Jilin Five-Star Animal Health
6.11.1 Jilin Five-Star Animal Health Company Information
6.11.2 Jilin Five-Star Animal Health Description and Business Overview
6.11.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
6.11.5 Jilin Five-Star Animal Health Recent Developments/Updates
6.12 NeoTech
6.12.1 NeoTech Company Information
6.12.2 NeoTech Description and Business Overview
6.12.3 NeoTech Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NeoTech Canine Vaccine Product Portfolio
6.12.5 NeoTech Recent Developments/Updates
6.13 JINHE
6.13.1 JINHE Company Information
6.13.2 JINHE Description and Business Overview
6.13.3 JINHE Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 JINHE Canine Vaccine Product Portfolio
6.13.5 JINHE Recent Developments/Updates
6.14 SINOVAC
6.14.1 SINOVAC Company Information
6.14.2 SINOVAC Description and Business Overview
6.14.3 SINOVAC Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 SINOVAC Canine Vaccine Product Portfolio
6.14.5 SINOVAC Recent Developments/Updates
6.15 Biogenesis Bago
6.15.1 Biogenesis Bago Company Information
6.15.2 Biogenesis Bago Description and Business Overview
6.15.3 Biogenesis Bago Canine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Biogenesis Bago Canine Vaccine Product Portfolio
6.15.5 Biogenesis Bago Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Canine Vaccine Industry Chain Analysis
7.2 Canine Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Canine Vaccine Production Mode & Process
7.4 Canine Vaccine Sales and Marketing
7.4.1 Canine Vaccine Sales Channels
7.4.2 Canine Vaccine Distributors
7.5 Canine Vaccine Customers
8 Canine Vaccine Market Dynamics
8.1 Canine Vaccine Industry Trends
8.2 Canine Vaccine Market Drivers
8.3 Canine Vaccine Market Challenges
8.4 Canine Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Canine Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Canine Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Canine Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Canine Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Canine Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Canine Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Canine Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Canine Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Canine Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Canine Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Canine Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Canine Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Canine Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Canine Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Canine Vaccine Sales by Region (2019-2024) & (K Units)
 Table 18. Global Canine Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Canine Vaccine Sales by Region (2025-2030) & (K Units)
 Table 20. Global Canine Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Canine Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Canine Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Canine Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Canine Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Canine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Canine Vaccine Sales by Country (2019-2024) & (K Units)
 Table 27. North America Canine Vaccine Sales by Country (2025-2030) & (K Units)
 Table 28. North America Canine Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Canine Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Canine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Canine Vaccine Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Canine Vaccine Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Canine Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Canine Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Canine Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Canine Vaccine Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Canine Vaccine Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Canine Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Canine Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Canine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Canine Vaccine Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Canine Vaccine Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Canine Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Canine Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Canine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Canine Vaccine Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Canine Vaccine Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Canine Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Canine Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Canine Vaccine Sales (K Units) by Type (2019-2024)
 Table 51. Global Canine Vaccine Sales (K Units) by Type (2025-2030)
 Table 52. Global Canine Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Canine Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Canine Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Canine Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Canine Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Canine Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Canine Vaccine Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Canine Vaccine Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Canine Vaccine Sales (K Units) by Application (2019-2024)
 Table 61. Global Canine Vaccine Sales (K Units) by Application (2025-2030)
 Table 62. Global Canine Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Canine Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Canine Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Canine Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Canine Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Canine Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Canine Vaccine Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Canine Vaccine Price (US$/Unit) by Application (2025-2030)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Zoetis Canine Vaccine Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Animal Health Company Information
 Table 76. Merck Animal Health Description and Business Overview
 Table 77. Merck Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Merck Animal Health Canine Vaccine Product
 Table 79. Merck Animal Health Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Pfizer Canine Vaccine Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Boehringer Ingelheim Company Information
 Table 86. Boehringer Ingelheim Description and Business Overview
 Table 87. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Boehringer Ingelheim Canine Vaccine Product
 Table 89. Boehringer Ingelheim Recent Developments/Updates
 Table 90. Virbac Company Information
 Table 91. Virbac Description and Business Overview
 Table 92. Virbac Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Virbac Canine Vaccine Product
 Table 94. Virbac Recent Developments/Updates
 Table 95. Durvet Company Information
 Table 96. Durvet Description and Business Overview
 Table 97. Durvet Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Durvet Canine Vaccine Product
 Table 99. Durvet Recent Developments/Updates
 Table 100. Elanco Company Information
 Table 101. Elanco Description and Business Overview
 Table 102. Elanco Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Elanco Canine Vaccine Product
 Table 104. Elanco Recent Developments/Updates
 Table 105. RuiPu Bio-Technology Company Information
 Table 106. RuiPu Bio-Technology Description and Business Overview
 Table 107. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. RuiPu Bio-Technology Canine Vaccine Product
 Table 109. RuiPu Bio-Technology Recent Developments/Updates
 Table 110. CAHIC Company Information
 Table 111. CAHIC Description and Business Overview
 Table 112. CAHIC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. CAHIC Canine Vaccine Product
 Table 114. CAHIC Recent Developments/Updates
 Table 115. Wuhan Keqian Biology Company Information
 Table 116. Wuhan Keqian Biology Description and Business Overview
 Table 117. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Wuhan Keqian Biology Canine Vaccine Product
 Table 119. Wuhan Keqian Biology Recent Developments/Updates
 Table 120. Jilin Five-Star Animal Health Company Information
 Table 121. Jilin Five-Star Animal Health Description and Business Overview
 Table 122. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Jilin Five-Star Animal Health Canine Vaccine Product
 Table 124. Jilin Five-Star Animal Health Recent Developments/Updates
 Table 125. NeoTech Company Information
 Table 126. NeoTech Description and Business Overview
 Table 127. NeoTech Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. NeoTech Canine Vaccine Product
 Table 129. NeoTech Recent Developments/Updates
 Table 130. JINHE Company Information
 Table 131. JINHE Description and Business Overview
 Table 132. JINHE Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. JINHE Canine Vaccine Product
 Table 134. JINHE Recent Developments/Updates
 Table 135. SINOVAC Company Information
 Table 136. SINOVAC Description and Business Overview
 Table 137. SINOVAC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. SINOVAC Canine Vaccine Product
 Table 139. SINOVAC Recent Developments/Updates
 Table 140. Biogenesis Bago Company Information
 Table 141. Biogenesis Bago Description and Business Overview
 Table 142. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Biogenesis Bago Canine Vaccine Product
 Table 144. Biogenesis Bago Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Canine Vaccine Distributors List
 Table 148. Canine Vaccine Customers List
 Table 149. Canine Vaccine Market Trends
 Table 150. Canine Vaccine Market Drivers
 Table 151. Canine Vaccine Market Challenges
 Table 152. Canine Vaccine Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Canine Vaccine
 Figure 2. Global Canine Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Canine Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Core Vaccines Product Picture
 Figure 5. Non-Core Vaccines Product Picture
 Figure 6. Global Canine Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Canine Vaccine Market Share by Application: 2023 & 2030
 Figure 8. Puppies
 Figure 9. Adult Dogs
 Figure 10. Global Canine Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Canine Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Canine Vaccine Sales (2019-2030) & (K Units)
 Figure 13. Global Canine Vaccine Average Price (US$/Unit) & (2019-2030)
 Figure 14. Canine Vaccine Report Years Considered
 Figure 15. Canine Vaccine Sales Share by Manufacturers in 2023
 Figure 16. Global Canine Vaccine Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Canine Vaccine Players: Market Share by Revenue in Canine Vaccine in 2023
 Figure 18. Canine Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Canine Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Canine Vaccine Sales Market Share by Country (2019-2030)
 Figure 21. North America Canine Vaccine Revenue Market Share by Country (2019-2030)
 Figure 22. United States Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Canine Vaccine Sales Market Share by Country (2019-2030)
 Figure 25. Europe Canine Vaccine Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Canine Vaccine Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Canine Vaccine Revenue Market Share by Region (2019-2030)
 Figure 33. China Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Canine Vaccine Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Canine Vaccine Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Canine Vaccine Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Canine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Canine Vaccine by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Canine Vaccine by Type (2019-2030)
 Figure 52. Global Canine Vaccine Price (US$/Unit) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Canine Vaccine by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Canine Vaccine by Application (2019-2030)
 Figure 55. Global Canine Vaccine Price (US$/Unit) by Application (2019-2030)
 Figure 56. Canine Vaccine Value Chain
 Figure 57. Canine Vaccine Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona